|
|
Description:
|
Method of assessment
|
|
Information:
|
The method of assessment is used in the submission of Individual Case Safety Reports (ICSRs) and Suspected Unexpected Serious Adverse Reactions (SUSARs) using ISO 27953-2:2011. This value is used in combination with its OID to identify causality assessment of suspect drugs and reported events/reactions that have used the European Union (EU) method described in the EU ICSR implementation guide.
|
|
First Registration Authority
|
|
|
|
|
Address:
|
European Medicines Agency
30 Churchill Place, Canary Wharf, London E14 5EU
United Kingdom (the)
|
|
|
Creation date:
|
25 September 2014
|
|
Disclaimer: The owner of this site does not warrant or assume any liability or responsibility for the accuracy, completeness, or usefulness of any information available on this page (for more information, please read the complete disclaimer).
All rights reserved, Orange © 2024 |